This document will assist industry, particularly labelers,
As defined under 21 CFR 801.3, and FDA staff in understanding
FDA’s requirements for direct marking of devices for unique device
Identification purposes.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3yAc3sn
No comments:
Post a Comment